Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
2
×
gene therapy
hemophilia
2
×
life sciences
national blog main
national top stories
new york blog main
2
×
new york top stories
spinal muscular atrophy
zolgensma
2
×
achromatopsia
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
beta-thalassemia
bill cassidy
biotech
bluebird bio
boxer capital
clinical trials
dna
dravet syndrome
ed kaye
encoded therapeutics
fda
generation bio
harvard pilgrim health care
illumina
illumina ventures
johnson & johnson
luxturna
mark warner
mathai mammen
matrix capital management
medicaid
meiragtx
What
gene
therapy
age
bigger
biggest
come
crude
cutting
deal
despite
edge
effects
emerging
encoded
gave
help
illumina’s
j
johnson
lasting
limited
limits
long
medicine
meiragtx
morning
nabs
past
progress
promising
push
remains
signal
signals
single
therapy’s
treatment
years
Language
Current search:
deals
×
zolgensma
×
hemophilia
×
" new york blog main "
×
@xconomy.com
5 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy